Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3080 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

CuraGen sells five million shares of TopoTarget

After expenses, CuraGen will receive approximately $12 million in cash. Timothy Shannon, president and CEO of CuraGen, said: “We also retain further potential upside related to belinostat consisting

Takeda San Francisco names new president and CSO

Dr Haak-Frendscho will be responsible for leading all activities at Takeda San Francisco including overall research and preclinical development, process development studies and operations for antibody therapeutics. Most

Clarient CFO to resign

Mr Agnello is expected to continue to serve as CFO until his successor is appointed and to remain with the company as an employee or consultant for a